Turkey using drug from China for coronavirus

Image
AFP Ankara
Last Updated : Mar 24 2020 | 1:24 AM IST

Turkey's health minister said Monday that the country is using a drug sent from China on patients suffering from the novel coronavirus.

"From this morning we have brought a special drug used in China which is claimed to have resulted in improvements in intensive care patients, cutting their time in care from 11-12 days to four days," Fahrettin Koca told reporters.

He did not give more information on the drug but the anti-malarial drug chloroquine has recently been used to treat coronavirus patients in China as well as France.

Some researchers have said chloroquine shows great promise, though scientists have agreed that only more trials would determine if it really works and is safe.

According to figures released late Sunday, Turkey has officially recorded 1,236 coronavirus cases and 30 deaths.

Koca said 50,000 rapid detection kits had arrived from China on Monday and had begun to be used, with 300,000 expected by Thursday.

The minister added that the Chinese government agreed with Turkey to share information on the novel coronavirus as the two countries step up cooperation to fight against the virus.

While Koca did not detail where the positive cases were in Turkey, he said the virus had spread across the country.

He did say there were fewer than 10 cases in Turkey's Van province, which borders badly-hit Iran.

He also said some health workers had caught the coronavirus, without giving specific figures.

A further 32,000 health workers would be employed during the crisis, he told a press conference in Ankara.

Koca also said that face masks produced in Turkey "will not be exported" as the country was in need.

There had been speculation Koca might announce a state of emergency, but he urged Turks to "announce their own state of emergency" as he insisted citizens adhere to measures already announced by Ankara.

Turkish authorities have ordered those aged 65 and above and those with chronic illnesses to stay at home, while most public spaces have been temporarily shut.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 24 2020 | 1:24 AM IST

Next Story